Cancer news covering oncology trials, treatment advances, screening guidelines, epidemiology, and patient outcomes.
Researchers at Queen's University Belfast, led by Rutuja N Meshram and Professor Dimitrios A Lamprou, developed a dissolvable 3D-printed patch using microneedles to deliver curcumin and 5-fluorouracil directly into the skin. The findings were published in Advanced Healthcare Materials, offering a less painful alternative to traditional injections or repeated topical applications for localized skin cancer treatment.
Researchers identified lymph node-like immune structures in the bone marrow of mouse skulls that protect the brain. Disrupting these structures accelerated tumor growth, while boosting them with immune proteins extended survival in glioblastoma models.
BBC News reports on Jason Walker, a terminally ill father from Lancashire determined to walk his daughter down the aisle in Montenegro. The article details his twelve-year battle with blood cancer and current clinical trial at Manchester's Christie Hospital as he seeks remission for this final goal.
Macmillan Cancer Support reports over 100,000 more men are living with prostate cancer in the UK compared to 2020. Experts attribute the surge to an ageing population, improved diagnostics, and increased awareness, while black men and those with family history face elevated risk.
This collection of personal essays argues that pediatric cancer research is critically underfunded, receiving only four cents of every federal dollar. Through the story of Sabina McMahon, a teen battling osteosarcoma, the pieces highlight the emotional toll on families and advocate for increased investment in pediatric oncology.
A JAMA Dermatology meta-analysis of 17 studies confirms that severe sunburns substantially increase the likelihood of developing cutaneous squamous cell carcinoma. High-frequency burns raised odds by 69 percent, while frequent childhood burns tripled the risk.
New research published in Cell Host & Microbe identifies a "mouth-to-feces" index measuring shared microbial variants between oral and digestive systems. Analysis of 507 volunteers showed significantly higher scores in cancer patients, offering a potential non-invasive screening method for gastric and colorectal diseases.
Japan's health ministry will soon inform women undergoing municipal breast cancer screenings about their breast density. This policy reverses the government's longtime opposition to disclosing such information, a change long advocated by health campaigners for greater transparency.
Orum Therapeutics will initiate a first-in-human Phase 1 clinical study of its investigational drug ORM-1153 by the end of 2026. The trial targets patients with relapsed or refractory acute myeloid leukemia and other hematologic malignancies, initially enrolling approximately 42 patients at U.S. sites.
New studies indicate laser ablation clearing over 91 percent of glioblastoma tumors extended patient survival to 2.1 years. The procedure uses a robotically controlled probe to heat and kill tumor cells while sparing healthy tissue, though experts caution it is not yet proven superior to standard surgery.